(MENAFN- EIN Presswire) rna-based-therapeutics-market
PORTLAND, OREGON, UNITED STATES, April 17, 2023 /einpresswire.com / -- RNA-based therapeutics are a type of medicine that use RNA molecules to treat diseases. RNA stands for ribonucleic acid, which is a molecule that plays a key role in the production of proteins in the body. RNA-based therapeutics work by targeting specific RNA molecules in the body to either enhance or inhibit their activity, which can have therapeutic effects.
The rna-based therapeutic market is the industry that produces and sells these types of medicines. This market has been growing rapidly in recent years due to advances in RNA technology and the potential for RNA-based therapeutics to treat a wide range of diseases, including genetic disorders, cancer, and viral infections. Some examples of RNA-based therapeutics that are already on the market include mRNA vaccines for COVID-19 and RNA-based treatments for certain types of cancer.
Request a Sample Copy of the Research Report:
According to the report, the global RNA based therapeutics industry was estimated at $4.93 billion in 2021, and is anticipated to hit $25.12 billion by 2030, registering a CAGR of 17.6% from 2021 to 2030.
Here are some common segments used in RNA-based therapeutics:
mRNA therapeutics: These are RNA molecules that provide instructions for the body's cells to produce proteins that can treat or prevent diseases.
siRNA therapeutics: These are small RNA molecules that can silence or reduce the activity of specific genes associated with diseases.
Antisense oligonucleotide therapeutics: These are short RNA molecules that can bind to and alter the activity of specific RNA molecules in the body.
Delivery methods: RNA-based therapeutics can be delivered to the body using various methods, such as lipid nanoparticles, electroporation, or viral vectors.
Therapeutic applications: RNA-based therapeutics can be used to treat a variety of diseases, including genetic disorders, cancer, infectious diseases, and rare diseases.
These segments are not mutually exclusive, and many RNA-based therapeutics may fall into multiple categories depending on their specific characteristics and applications.
Impact of COVID-19 on RNA Based Therapeutics Market-
There was a steep decline in the number of patients visiting clinics and hospitals for RNA based therapies, which, in turn, decreased the demand for RNA based therapeutic products, especially during the initial phase of the pandemic. This impacted the global RNA based therapeutic market negatively.
Also, mRNA vaccines could potentially offer long-term solutions all over the world for diseases ranging from influenza to AIDS, but owing to lockdown measures and temporary closure of research institutes and academic research, the demand for RNA based therapeutic solutions decreased significantly.
This trend is quite likely to continue till the pandemic is completely over.
Get detailed COVID-19 impact analysis on the RNA Based Therapeutic Market-
There are several factors that can impact the RNA-based therapeutic market, but here are some of the top ones:
Advancements in RNA technology: The development of new RNA-based therapeutic platforms, such as mRNA vaccines and RNA interference (RNAi) therapies, has significantly expanded the potential applications of RNA-based therapeutics.
Increasing prevalence of chronic diseases: The prevalence of chronic diseases such as cancer, diabetes, and cardiovascular diseases is increasing globally, driving the demand for new and effective treatments.
Growing investment in RNA-based therapeutics: The RNA-based therapeutic market has attracted significant investment from both private and public sectors, which has helped to accelerate research and development efforts and bring new products to market.
Regulatory landscape: The regulatory landscape for RNA-based therapeutics is evolving rapidly, with new guidelines and regulations being developed to ensure the safety and efficacy of these products.
COVID-19 pandemic: The COVID-19 pandemic has accelerated the development and adoption of mRNA vaccines, which has increased public awareness of RNA-based therapeutics and their potential applications.
These factors are likely to continue to shape the RNA-based therapeutic market in the coming years, driving innovation, investment, and growth in this sector.
For Purchase Inquiry-
Here are the top 10 companies in the RNA-based therapeutic market, based on their revenue and market share:
Moderna Inc.
BioNTech SE
Alnylam Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc.
Ionis Pharmaceuticals Inc.
CRISPR Therapeutics AG
Translate Bio Inc.
Sarepta Therapeutics Inc.
Silence Therapeutics plc
Regulus Therapeutics Inc.
Similar Research Reports for Information, Communication and Technology:
cancer diagnostics market
chromatography market
About Allied Market Research:
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domains. AMR offers its services across 11 industry verticals including Life Sciences, Consumer Goods, Materials & Chemicals, Construction & Manufacturing, Food & Beverages, Energy & Power, Semiconductor & Electronics, Automotive & Transportation, ICT & Media, Aerospace & Defense, and BFSI.
David Correa
Allied Analytics LLP
+1-800-792-5285
email us here